Across the CEO’s Desk: February 2015 Roundup February 27, 2015December 14, 2022 Jill O'Donnell-Tormey, PhD
New Cancer Immunotherapy Opdivo Approved by FDA December 22, 2014December 14, 2022 Jill O'Donnell-Tormey, PhD
ASH14 Preview: Blood Cancer Developments December 1, 2014December 14, 2022 Jill O'Donnell-Tormey, PhD